One of the first studies investigating the association between lung cancer risk and mEH genotypes was conducted by Benhamou et al (1998), who found a significant dose–response relationship between predicted enzyme activity and lung cancer risk in French Caucasian smokers. This evidence concerns the gene EPHX1 and lung carcinoma.